fluoroscopy

(redirected from Fluoroscopic procedures)
Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to Fluoroscopic procedures: Flouroscope

fluoroscopy

 [floo͡″ros´kah-pe]
examination by means of the fluoroscope.

fluor·os·co·py

(flōr-os'kŏ-pē),
Examination of the tissues and deep structures of the body by x-ray, using the fluoroscope or its successor, video fluoroscopy (q.v.).

fluoroscopy

/flu·o·ros·co·py/ (fldbobr-ros´kah-pe) examination by means of the fluoroscope.

fluoroscopy

(flo͝o-rŏs′kə-pē, flô-, flō-)
n. pl. fluorosco·pies
Examination by means of a fluoroscope.

fluo·ros′co·pist n.

fluoroscopy

[floo͡ros′kəpē]
the visual examination of a part of the body or the function of an organ with a fluoroscope. The technique offers continuous imaging of the motion of internal structures and immediate serial images. It is invaluable in many clinical procedures, such as intrauterine fetal transfusion and cardiac catheterization.

fluoroscopy

Imaging An x-ray imaging technique used to evaluate moving pulmonary and cardiac structures, and help in needle localization of masses being biopsied Cons Fluoroscopy exposed Pts to more radiation than a standard film; small lesions can be overlooked, there is no permanent record. Cf Computed tomography.

fluor·os·co·py

(flōr-os'kŏ-pē)
Examination of the tissues and deep structures of the body by x-ray, using a fluoroscope.

Fluoroscopic (fluoroscopy)

An x-ray procedure that produces immediate images and motion on a screen. The images look like those seen at airport baggage security stations.

fluoroscopy

radiographic imaging technique allowing visualization of both bone and soft tissues

fluoroscopy

examination by means of the fluoroscope, a fluoroscopic screen set up to produce a visual image.
References in periodicals archive ?
noted that while fluoroscopic procedures have dramatically improved patient care and outcomes, the rapid rise in the use of ionizing radiation has renewed concerns about exposure during medical imaging.
In addition to the matters described above, the ability of the Company to develop its products, market acceptance and future sales of the VenaCure(TM) Laser Vein Treatment System, results of the pending patent litigation with Diomed, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from Group Purchasing Organizations, competition, including alternative procedures which continue to replace traditional fluoroscopic procedures, as well as the risk factors listed from time to time in the SEC filings of AngioDynamics Inc.
With the addition of mobile, flat detector technology, the AXIOM Sireskop SD provides a single system for all digital radiographic and fluoroscopic procedures.
Military, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from Group Purchasing Organizations, competition, including alternative procedures which continue to replace traditional fluoroscopic procedures, as well as the risk factors listed from time to time in the SEC filings of E-Z-EM, Inc.
In addition to the matters described above, the ability of the Company to develop its products, market acceptance and future sales of the VenaCure(TM) Laser Vein Treatment System and the new procedure kit, results of the pending patent litigation with Diomed, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from Group Purchasing Organizations, competition, including alternative procedures which continue to replace traditional fluoroscopic procedures, as well as the risk factors listed from time to time in the SEC filings of AngioDynamics Inc.
In addition to the matters described above, the ability of the Company to develop its products, first responder market acceptance and sales of RSDL, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from Group Purchasing Organizations, competition, including alternative procedures which continue to replace traditional fluoroscopic procedures, as well as the risk factors listed from time to time in the SEC filings of E-Z-EM, Inc.
In addition to the matters described above, the ability of the Company to develop its products, market acceptance and future sales of the MORPHEUS(TM) CT Injectable PICC, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from Group Purchasing Organizations, competition, including alternative procedures which continue to replace traditional fluoroscopic procedures, as well as the risk factors listed from time to time in the SEC filings of E-Z-EM, Inc.
In addition to the matters described above, the ability of the Company to develop its products, market acceptance and future sales of the Dynamic Flow(TM) chronic hemodialysis catheter, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from Group Purchasing Organizations, competition, including alternative procedures which continue to replace traditional fluoroscopic procedures, as well as the risk factors listed from time to time in the SEC filings of E-Z-EM, Inc.